$15.00
0.10.67%
At close: -
$15.00
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Adient Analyst Ratings and Price Targets | NYSE:ADNT | Benzinga
Adient PLC has a consensus price target of $24.54 based on the ratings of 15 analysts. The high is $62 issued by Benchmark on August 7, 2023. The low is $13 issued by Barclays on April 15, 2025. The 3 most-recent analyst ratings were released by Morgan Stanley, Wells Fargo, and UBS on May 19, 2025, May 19, 2025, and May 8, 2025, respectively. With an average price target of $16 between Morgan Stanley, Wells Fargo, and UBS, there's an implied 6.67% upside for Adient PLC from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Wells Fargo
UBS
Citigroup
Barclays
1calculated from analyst ratings
Analyst Ratings for Adient
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/19/2025 | Buy Now | 6.67% | Morgan Stanley | Adam Jonas63% | $17 → $16 | Maintains | Underweight | Get Alert |
| 05/19/2025 | Buy Now | 13.33% | Wells Fargo | Colin Langan49% | $14 → $17 | Maintains | Equal-Weight | Get Alert |
| 05/08/2025 | Buy Now | — | UBS | Joseph Spak43% | $13 → $15 | Maintains | Neutral | Get Alert |
| 05/08/2025 | Buy Now | -6.67% | Wells Fargo | Colin Langan49% | $13 → $14 | Maintains | Equal-Weight | Get Alert |
| 04/23/2025 | Buy Now | -6.67% | Citigroup | Michael Ward77% | → $14 | Initiates | → Neutral | Get Alert |
| 04/15/2025 | Buy Now | -13.33% | Barclays | Dan Levy45% | $21 → $13 | Maintains | Equal-Weight | Get Alert |
| 04/10/2025 | Buy Now | -13.33% | UBS | Joseph Spak43% | $20 → $13 | Maintains | Neutral | Get Alert |
| 03/04/2025 | Buy Now | 20% | B of A Securities | John Murphy54% | $24 → $18 | Downgrade | Neutral → Underperform | Get Alert |
| 03/03/2025 | Buy Now | 13.33% | Morgan Stanley | Adam Jonas63% | $19 → $17 | Maintains | Underweight | Get Alert |
| 01/29/2025 | Buy Now | 33.33% | UBS | Joseph Spak43% | $19 → $20 | Maintains | Neutral | Get Alert |
| 01/27/2025 | Buy Now | 40% | JP Morgan | Ryan Brinkman53% | $24 → $21 | Maintains | Neutral | Get Alert |
| 01/22/2025 | Buy Now | 40% | Barclays | Dan Levy45% | $24 → $21 | Maintains | Equal-Weight | Get Alert |
| 12/16/2024 | Buy Now | 33.33% | Wells Fargo | Colin Langan49% | $27 → $20 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/21/2024 | Buy Now | 60% | B of A Securities | John Murphy54% | $30 → $24 | Downgrade | Buy → Neutral | Get Alert |
| 11/14/2024 | Buy Now | 26.67% | Morgan Stanley | Adam Jonas63% | $21 → $19 | Maintains | Underweight | Get Alert |
| 10/14/2024 | Buy Now | 100% | B of A Securities | John Murphy54% | $35 → $30 | Maintains | Buy | Get Alert |
| 09/20/2024 | Buy Now | 80% | Wells Fargo | Colin Langan49% | $29 → $27 | Maintains | Overweight | Get Alert |
| 09/10/2024 | Buy Now | 60% | Deutsche Bank | Edison Yu33% | → $24 | Reinstates | → Hold | Get Alert |
| 09/05/2024 | Buy Now | — | Wolfe Research | Emmanuel Rosner72% | — | Initiates | → Peer Perform | Get Alert |
| 08/14/2024 | Buy Now | 40% | Morgan Stanley | Adam Jonas63% | $32 → $21 | Maintains | Underweight | Get Alert |
| 08/08/2024 | Buy Now | 80% | JP Morgan | Ryan Brinkman53% | $31 → $27 | Maintains | Neutral | Get Alert |
| 08/08/2024 | Buy Now | 60% | Barclays | Dan Levy45% | $29 → $24 | Maintains | Equal-Weight | Get Alert |
| 08/07/2024 | Buy Now | 60% | UBS | Joseph Spak43% | $27 → $24 | Maintains | Neutral | Get Alert |
| 07/22/2024 | Buy Now | 166.67% | B of A Securities | John Murphy54% | $42 → $40 | Maintains | Buy | Get Alert |
| 07/22/2024 | Buy Now | 106.67% | JP Morgan | Ryan Brinkman53% | $32 → $31 | Maintains | Neutral | Get Alert |
| 07/16/2024 | Buy Now | 93.33% | Barclays | Dan Levy45% | $34 → $29 | Maintains | Equal-Weight | Get Alert |
| 07/10/2024 | Buy Now | 80% | UBS | Colin Langan49% | $31 → $27 | Maintains | Neutral | Get Alert |
| 07/01/2024 | Buy Now | 73.33% | Exane BNP Paribas | James Picariello73% | → $26 | Upgrade | Underperform → Neutral | Get Alert |
| 06/25/2024 | Buy Now | 113.33% | Wells Fargo | Colin Langan49% | $33 → $32 | Maintains | Overweight | Get Alert |
| 05/10/2024 | Buy Now | 113.33% | Morgan Stanley | Adam Jonas63% | $35 → $32 | Maintains | Underweight | Get Alert |
| 05/07/2024 | Buy Now | 113.33% | JP Morgan | Ryan Brinkman53% | $37 → $32 | Maintains | Neutral | Get Alert |
| 05/07/2024 | Buy Now | 126.67% | Barclays | Dan Levy45% | $37 → $34 | Maintains | Equal-Weight | Get Alert |
| 05/06/2024 | Buy Now | 106.67% | UBS | Joseph Spak43% | $36 → $31 | Maintains | Neutral | Get Alert |
| 05/06/2024 | Buy Now | 100% | Deutsche Bank | Emmanuel Rosner72% | $32 → $30 | Maintains | Hold | Get Alert |
| 05/06/2024 | Buy Now | 120% | Wells Fargo | Colin Langan49% | $38 → $33 | Maintains | Overweight | Get Alert |
| 04/22/2024 | Buy Now | 146.67% | JP Morgan | Ryan Brinkman53% | $40 → $37 | Maintains | Neutral | Get Alert |
| 04/10/2024 | Buy Now | 146.67% | Barclays | Dan Levy45% | $41 → $37 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/10/2024 | Buy Now | 206.67% | B of A Securities | John Murphy54% | $50 → $46 | Maintains | Buy | Get Alert |
| 04/01/2024 | Buy Now | 153.33% | Wells Fargo | Colin Langan49% | $40 → $38 | Maintains | Overweight | Get Alert |
| 02/28/2024 | Buy Now | 166.67% | JP Morgan | Ryan Brinkman53% | $41 → $40 | Maintains | Neutral | Get Alert |
| 02/09/2024 | Buy Now | 173.33% | Barclays | Dan Levy45% | $43 → $41 | Maintains | Overweight | Get Alert |
| 02/08/2024 | Buy Now | 166.67% | Wells Fargo | Colin Langan49% | $41 → $40 | Maintains | Overweight | Get Alert |
| 01/24/2024 | Buy Now | 186.67% | Barclays | Dan Levy45% | $47 → $43 | Maintains | Overweight | Get Alert |
| 11/14/2023 | Buy Now | 133.33% | Morgan Stanley | Adam Jonas63% | $38 → $35 | Maintains | Underweight | Get Alert |
| 11/10/2023 | Buy Now | 213.33% | Barclays | Dan Levy45% | $52 → $47 | Maintains | Overweight | Get Alert |
| 11/09/2023 | Buy Now | 140% | UBS | Joseph Spak43% | $40 → $36 | Maintains | Neutral | Get Alert |
| 11/09/2023 | Buy Now | 173.33% | Wells Fargo | Colin Langan49% | $49 → $41 | Maintains | Overweight | Get Alert |
| 10/13/2023 | Buy Now | 246.67% | Barclays | Dan Levy45% | $54 → $52 | Maintains | Overweight | Get Alert |
| 10/10/2023 | Buy Now | 166.67% | UBS | Colin Langan49% | $43 → $40 | Maintains | Neutral | Get Alert |
| 09/13/2023 | Buy Now | 186.67% | UBS | Colin Langan49% | → $43 | Initiates | → Neutral | Get Alert |
| 08/08/2023 | Buy Now | 153.33% | Morgan Stanley | Adam Jonas63% | $35 → $38 | Maintains | Underweight | Get Alert |
| 08/07/2023 | Buy Now | 313.33% | Benchmark | Michael Ward77% | $58 → $62 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | 260% | Barclays | Dan Levy45% | $50 → $54 | Maintains | Overweight | Get Alert |
| 07/20/2023 | Buy Now | 180% | JP Morgan | Ryan Brinkman53% | $38 → $42 | Maintains | Neutral | Get Alert |
| 07/10/2023 | Buy Now | 200% | Wells Fargo | Colin Langan49% | $48 → $45 | Maintains | Overweight | Get Alert |
| 06/01/2023 | Buy Now | — | Exane BNP Paribas | James Picariello73% | — | Downgrade | Neutral → Underperform | Get Alert |
| 05/04/2023 | Buy Now | 220% | Wells Fargo | Colin Langan49% | $49 → $48 | Maintains | Overweight | Get Alert |
| 05/04/2023 | Buy Now | 233.33% | Barclays | Dan Levy45% | $54 → $50 | Maintains | Overweight | Get Alert |
| 04/17/2023 | Buy Now | 260% | Barclays | Dan Levy45% | $57 → $54 | Maintains | Overweight | Get Alert |
| 04/10/2023 | Buy Now | 226.67% | Wells Fargo | Colin Langan49% | $50 → $49 | Maintains | Overweight | Get Alert |
| 02/15/2023 | Buy Now | 280% | Barclays | Dan Levy45% | → $57 | Initiates | → Overweight | Get Alert |
| 02/09/2023 | Buy Now | 133.33% | Morgan Stanley | Adam Jonas63% | $29 → $35 | Maintains | Underweight | Get Alert |
| 02/09/2023 | Buy Now | — | Wolfe Research | Rod Lache71% | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 02/08/2023 | Buy Now | 233.33% | Wells Fargo | Colin Langan49% | $46 → $50 | Maintains | Overweight | Get Alert |
| 02/08/2023 | Buy Now | 300% | Benchmark | Michael Ward77% | $48 → $60 | Maintains | Buy | Get Alert |
| 01/25/2023 | Buy Now | 153.33% | JP Morgan | Ryan Brinkman53% | $35 → $38 | Maintains | Neutral | Get Alert |
| 01/17/2023 | Buy Now | 206.67% | Wells Fargo | Colin Langan49% | $41 → $46 | Maintains | Overweight | Get Alert |
| 01/09/2023 | Buy Now | 246.67% | B of A Securities | John Murphy54% | $41 → $52 | Upgrade | Neutral → Buy | Get Alert |
| 11/28/2022 | Buy Now | 93.33% | Morgan Stanley | Adam Jonas63% | $27 → $29 | Maintains | Underweight | Get Alert |
| 11/08/2022 | Buy Now | 160% | Deutsche Bank | Emmanuel Rosner72% | → $39 | Downgrade | Buy → Hold | Get Alert |
| 11/07/2022 | Buy Now | 180% | Wells Fargo | Colin Langan49% | $37 → $42 | Maintains | Overweight | Get Alert |
| 11/07/2022 | Buy Now | 140% | RBC Capital | Joseph Spak43% | → $36 | Downgrade | Outperform → Sector Perform | Get Alert |
| 09/09/2022 | Buy Now | 173.33% | B of A Securities | John Murphy54% | $48 → $41 | Maintains | Neutral | Get Alert |
| 08/08/2022 | Buy Now | 200% | Wells Fargo | Colin Langan49% | $41 → $45 | Maintains | Overweight | Get Alert |
| 07/14/2022 | Buy Now | 80% | Morgan Stanley | Adam Jonas63% | $31 → $27 | Maintains | Underweight | Get Alert |
| 07/11/2022 | Buy Now | 173.33% | Wells Fargo | Colin Langan49% | $43 → $41 | Maintains | Overweight | Get Alert |
| 06/02/2022 | Buy Now | 106.67% | Morgan Stanley | Adam Jonas63% | $36 → $31 | Maintains | Underweight | Get Alert |
FAQ
What is the target price for Adient (ADNT) stock?
The latest price target for Adient (NYSE:ADNT) was reported by Morgan Stanley on May 19, 2025. The analyst firm set a price target for $16.00 expecting ADNT to rise to within 12 months (a possible 6.67% upside). 29 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Adient (ADNT)?
The latest analyst rating for Adient (NYSE:ADNT) was provided by Morgan Stanley, and Adient maintained their underweight rating.
When was the last upgrade for Adient (ADNT)?
The last upgrade for Adient PLC happened on July 1, 2024 when Exane BNP Paribas raised their price target to $26. Exane BNP Paribas previously had an underperform for Adient PLC.
When was the last downgrade for Adient (ADNT)?
The last downgrade for Adient PLC happened on March 4, 2025 when B of A Securities changed their price target from $24 to $18 for Adient PLC.
When is the next analyst rating going to be posted or updated for Adient (ADNT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Adient, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Adient was filed on May 19, 2025 so you should expect the next rating to be made available sometime around May 19, 2026.
Is the Analyst Rating Adient (ADNT) correct?
While ratings are subjective and will change, the latest Adient (ADNT) rating was a maintained with a price target of $17.00 to $16.00. The current price Adient (ADNT) is trading at is $15.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
